Your browser doesn't support javascript.
loading
Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study.
Caponnetto, Valeria; Russo, Antonio; Silvestro, Marcello; Tessitore, Alessandro; De Icco, Roberto; Vaghi, Gloria; Sances, Grazia; Tassorelli, Cristina; Baraldi, Carlo; Castro, Flavia Lo; Guerzoni, Simona; Prudenzano, Maria Pia; Fallacara, Adriana; Gentile, Martino; Ornello, Raffaele; Onofri, Agnese; Burgalassi, Andrea; Chiarugi, Alberto; De Cesaris, Francesco; Granato, Antonio; Casalena, Alfonsina; De Tommaso, Marina; Mampreso, Edoardo; Merlo, Paola; Coppola, Gianluca; Battistini, Stefania; Rebecchi, Valentina; Rainero, Innocenzo; Sepe, Federica Nicoletta; Dalla Volta, Giorgio; Sacco, Simona; Geppetti, Pierangelo; Iannone, Luigi Francesco.
Afiliação
  • Caponnetto V; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Russo A; Department of Advanced Medical and Surgical Sciences, Headache Centre, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Silvestro M; Department of Advanced Medical and Surgical Sciences, Headache Centre, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • Tessitore A; Department of Advanced Medical and Surgical Sciences, Headache Centre, University of Campania "Luigi Vanvitelli", Naples, Italy.
  • De Icco R; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Vaghi G; Headache Science and Neurorehabilitation Center, IRCCS Mondino Foundation, Pavia, Italy.
  • Sances G; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Tassorelli C; Headache Science and Neurorehabilitation Center, IRCCS Mondino Foundation, Pavia, Italy.
  • Baraldi C; Headache Science and Neurorehabilitation Center, IRCCS Mondino Foundation, Pavia, Italy.
  • Castro FL; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
  • Guerzoni S; Headache Science and Neurorehabilitation Center, IRCCS Mondino Foundation, Pavia, Italy.
  • Prudenzano MP; Laboratory of Clinical Pharmacology and Pharmacogenomics, Department of Specialist Medicines, Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse, AOU Policlinico di Modena, Modena, Italy.
  • Fallacara A; Laboratory of Clinical Pharmacology and Pharmacogenomics, Department of Specialist Medicines, Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse, AOU Policlinico di Modena, Modena, Italy.
  • Gentile M; Laboratory of Clinical Pharmacology and Pharmacogenomics, Department of Specialist Medicines, Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse, AOU Policlinico di Modena, Modena, Italy.
  • Ornello R; Headache Center, Amaducci Neurological Clinic, Policlinico General Hospital, Bari, Italy.
  • Onofri A; Headache Center, Amaducci Neurological Clinic, Policlinico General Hospital, Bari, Italy.
  • Burgalassi A; Headache Center, Amaducci Neurological Clinic, Policlinico General Hospital, Bari, Italy.
  • Chiarugi A; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • De Cesaris F; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Granato A; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy.
  • Casalena A; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy.
  • De Tommaso M; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy.
  • Mampreso E; Headache Center and Clinical Pharmacology Unit, Careggi University Hospital, Florence, Italy.
  • Merlo P; Clinical Unit of Neurology, Department of Medicine, Surgery and Health Sciences, Headache Centre, School of Neurology, University Hospital and Health Services of Trieste, ASUGI, University of Trieste, Trieste, Italy.
  • Coppola G; Neurology Unit, "G. Mazzini" Hospital, Teramo, Italy.
  • Battistini S; Department of Basic Medical Science, Neuroscience and Sense Organs, University of Bari Aldo Moro, Bari, Italy.
  • Rebecchi V; Headache Centre, Neurology-Euganea, Padua Health Unit, Padua, Italy.
  • Rainero I; Neurological Unit, Headache Centre, Humanitas Gavazzeni, Bergamo, Italy.
  • Sepe FN; Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome Polo Pontino ICOT, Latina, Italy.
  • Dalla Volta G; Neurology and Clinical Neurophysiology Unit, Headache Center, Siena University Hospital Department of Medical, Surgical and Neurological Sciences, University of Siena, Siena, Italy.
  • Sacco S; Neurology and Stroke Unit, ASST Sette Laghi, Varese, Italy.
  • Geppetti P; Department of Neuroscience "Rita Levi Montalcini", Headache Center, University of Torino, Torino, Italy.
  • Iannone LF; Neurology Department, Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
CNS Drugs ; 37(12): 1069-1080, 2023 12.
Article em En | MEDLINE | ID: mdl-37999868
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uso Excessivo de Medicamentos Prescritos / Transtornos de Enxaqueca Limite: Humans Idioma: En Revista: CNS Drugs Assunto da revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uso Excessivo de Medicamentos Prescritos / Transtornos de Enxaqueca Limite: Humans Idioma: En Revista: CNS Drugs Assunto da revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália